|
|
|
|
T-019 / T-019-1ML updated item number format
(-)-11-nor-9-Carboxy-Δ9-THC (Suitable for use with immunoassay)
1.0 mg/mL in Methanol | Certified Reference Material
|
|
An analytical reference standard suitable in cannabinoid testing, clinical toxicology, forensic analysis, or urine drug testing by LC-MS/MS or GC/MS. Also known as THC acid, 11-nor-9-Carboxy-Δ9-THC is the main secondary metabolite of THC found in urine or blood of cannabis users.
|
|
|
|
|
| Concentration:
|
1.0 mg/mL
|
| Solvent:
|
Methanol
|
| Unit Size:
|
1 mL/ampoule
|
| CAS Number:
|
56354-06-4
|
| Chemical Formula:
|
C21H28O4
|
| Molecular Weight:
|
344.44
|
| Certificate of Analysis:
|
|
| US List Price:
|
|
|
|
|
| T-003 / T-003-1ML |
|
(-)-Δ9-THC-D3, 100 μg/mL
|
|
$89.90
|
|
|
|
|
|
| T-004 / T-004-1ML |
|
(±)-11-nor-9-Carboxy-Δ9-THC-D3, 100 μg/mL
|
|
$46.90
|
|
|
|
|
|
| T-005 / T-005-1ML |
|
(-)-Δ9-THC, 1.0 mg/mL
|
|
$37.20
|
|
|
|
|
|
| T-006 / T-006-1ML |
|
(±)-11-nor-9-Carboxy-Δ9-THC (Racemic mixture - not to be used for immunoassay), 100 μg/mL
|
|
$38.80
|
|
|
|
|
|
| T-007 / T-007-1ML |
|
(±)-11-nor-9-Carboxy-Δ9-THC-D9, 100 μg/mL
|
|
$54.60
|
|
|
|
|
|
| T-008 / T-008-1ML |
|
(±)-11-nor-9-Carboxy-Δ9-THC-D3, 1.0 mg/mL
|
|
$264.00
|
|
|
|
|
|
| T-010 / T-010-1ML |
|
(±)-11-nor-9-Carboxy-Δ9-THC (Racemic mixture - not to be used for immunoassay), 1.0 mg/mL
|
|
$311.00
|
|
|
|
|
|
| T-011 / T-011-1ML |
|
(-)-Δ9-THC-D3, 1.0 mg/mL
|
|
$680.00
|
|
|
|
|
|
| T-018 / T-018-1ML |
|
(-)-11-nor-9-Carboxy-Δ9-THC (Suitable for use with immunoassay), 100 μg/mL
|
|
$44.10
|
|
|
|
|
|
| T-038 / T-038-1ML |
|
(+)-11-nor-9-Carboxy-Δ9- THC glucuronide, 100 μg/mL
|
|
$311.00
|
|
|
|
|
|
| T-080 / T-080-1ML |
|
(±)-cis-11-Nor-9-carboxy-Δ9-THC-D3 glucuronide, 100 μg/mL
|
|
$387.00
|
|
|
|
|
|
▶ A Validated Chiral HPLC Method for Resolution of ?8 and ?9 – Tetrahydrocannabinol Enantiomers | Tamara Tarbox, Isil Dilek PhD, Uma Sreenivasan PhD, Kenan Yaser, Cerilliant, 2009
|
|
▶ Investigation of the Impurities in Dronabinol Samples by LCMS | Huahua Jian, Isil Dilek, Uma Sreenivasan, Kenan Yaser, Cerilliant, 2010
|
|
▶ LC/MS (TOF) Analysis of Drugs and Their Glucuronide Metabolites on Titan™ C18 after Solid Phase Extraction (SPE) using Supel™-Select SCX, ß-Glucuronidase Enzyme Digestion | Sigma-Aldrich®, 2014
|
|
▶ Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples | Robert M. Sears, Toxicology Technical Leader , Kenneth Lewis, CEO , and Kim Gamble, President, ITSP Solutions, INC., 2014
|
|
▶ Using UHPLC/MS (TOF) for Detection of Drugs and Metabolites in Urine following Optimized Enzymatic Hydrolysis Conditions | Sigma-Aldrich®, 2015
|
|
|
|
|